Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group

Blood. 1994 Jul 15;84(2):666-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Middle Aged
  • Pilot Projects
  • Recurrence
  • Tretinoin / therapeutic use*

Substances

  • Tretinoin